Assoc. Prof. Dr. Monika Lejman | Cytogenetics | Best Researcher Award
Assoc. Prof. Dr. Monika Lejman | Medical University of Lublin | Poland
Dr. Monika Lejman is a seasoned geneticist with over two decades of experience in the field of medical genetics. She currently resides in Lublin, where she leads genetic diagnostics efforts at both the University Children’s Hospital and the Medical University of Lublin. Holding a post-doctoral degree and a PhD , she has demonstrated long-standing academic and professional excellence. As the Head of Genetic Diagnostics, her clinical and research work is primarily focused on pediatric hematologic malignancies and rare genetic disorders. She has authored multiple open-access research articles published in prestigious journals and is actively involved in mentoring and clinical innovations. Dr. Lejman has received top-level recognition, including the Rector’s Award for scientific achievements. Her commitment to translational research, diagnostic accuracy, and improving pediatric patient outcomes sets her apart as a leader in her field.
Publication Profiles:
Scopus
Orcid
Education:
Dr. Monika Lejman pursued her academic journey in biological sciences, starting with a Master’s degree from the Faculty of Biology and Biotechnology at UMCS, Lublin. Her academic excellence earned her several scientific scholarships and a diploma of appreciation from the Rector of UMCS. She was awarded a PhD, and she obtained a prestigious post-doctoral (habilitation) degree . Her educational foundation was laid at a high school , followed by primary education Additionally, she has professional qualifications as a Laboratory Diagnostician and was certified as a Specialist in the Laboratory of Medical Genetics . Her education combined strong theoretical knowledge with practical clinical applications, laying the groundwork for her innovative genetic diagnostics work. Her continuous professional development reflects her dedication to lifelong learning and excellence in medical genetics.
Experience:
Dr. Monika Lejman has over 25 years of professional experience, predominantly focused on genetic diagnostics in pediatric medicine. She has been associated with the Department of Genetic Diagnostics at the University Children’s Hospital in Lublin, where she currently serves as Head. Concurrently, she has been with the Medical University of Lublin, heading the Laboratory of Genetic Diagnostics in the Department of Pediatrics. Her responsibilities include overseeing genetic testing, clinical evaluations, and interdisciplinary collaboration in both academic and hospital settings. Under her leadership, the departments have expanded diagnostic capabilities and integrated innovative research into patient care. She also mentors medical students and researchers, ensuring knowledge transfer and development of future specialists. Her dual role bridges cutting-edge academic research and critical clinical services, establishing her as a cornerstone in the advancement of genetic diagnostics in Poland’s pediatric healthcare system.
Awards and Honors:
Dr. Monika Lejman has been recognized for her scientific and organizational contributions with the prestigious Rector’s Award of the First Degree for Scientific Achievements. This award is a testament to her impactful research in pediatric oncology and genetic disorders. Additionally, she received an organizational achievement award, acknowledging her exceptional leadership in managing complex diagnostic departments and enhancing service quality in pediatric genetic healthcare. Earlier in her academic career, she was awarded scholarships for scientific excellence throughout her university studies and received a diploma of appreciation from the Rector of UMCS for her outstanding academic performance. These accolades highlight both her early promise and her sustained contributions to the field. Her dedication to excellence has earned her a reputation as a respected clinician-scientist, committed to integrating scientific advancements with clinical practice to improve outcomes for children with rare and serious genetic conditions.
Research Focus:
Dr. Monika Lejman’s research is centered on pediatric genetic disorders, with a strong emphasis on acute lymphoblastic leukemia (ALL) and other hematologic malignancies in children. Her studies aim to uncover the cytogenetic and molecular landscape of these diseases to improve diagnostic precision and tailor treatment strategies. She is particularly interested in genomic aberrations, TCF3 mutations, loss of heterozygosity, and their prognostic significance. Additionally, her work extends to investigating gene expression in solid tumors like triple-negative breast cancer, and understanding inflammatory bowel diseases in pediatric populations. She also explores rare syndromes, such as Xia-Gibbs syndrome, providing insight into novel mutations. Dr. Lejman collaborates on long-term monitoring of donor chimerism post-transplant, genetic markers for thromboembolic risks, and the unique healthcare needs of refugee populations. Her research is not only cutting-edge but also clinically relevant, aiming to bridge gaps between diagnostics, treatment, and long-term care in pediatric medicine.
Publications Top Notes:
-
Cytogenetic landscape aberrations in paediatric acute lymphoblastic leukaemia — a Polish paediatric population treated according to ALL-IC BFM 2009 protocol
-
A novel approach to understanding the role of TCF3 mutations in childhood B-cell precursor acute lymphoblastic leukemia
-
Profiling the Expression Level of a Gene from the Caspase Family in Triple-Negative Breast Cancer
-
Loss of Heterozygosity in Pediatric Acute Lymphoblastic Leukemia and Its Prognostic Impact: A Retrospective Study
-
Thromboembolic Risk and High Prothrombotic Factors in Childhood Acute Lymphoblastic Leukemia with Ischemic Stroke: A Literature Review
-
Long-Term Donor Chimerism Monitoring for Relapse Risk Assessment After Pediatric Allo-HSCT
-
The Association of Polymorphisms in IL-6, IL-10, IL-6R, and IL-10R Genes with Pediatric Inflammatory Bowel Disease Risk
-
Diagnostic and clinical approach to a paediatric patient with skin aplasia of the head as a rare manifestation of Xia-Gibbs syndrome
-
Review of infections accompanied by paediatric acute lymphoblastic leukemia with emphasis on treatment of refugees
-
Biological Markers of Myeloproliferative Neoplasms in Children, Adolescents and Young Adults
Conclusion:
Dr. Monika Lejman is exceptionally well-qualified for the Best Researcher Award. She exemplifies the role of a modern clinician-scientist by bridging research, diagnostics, and patient care in the critical area of pediatric genetic disorders. Her extensive leadership, scholarly contributions, and institutional service make her a standout candidate. With continued focus on internationalization and research dissemination, she is poised to expand her already significant impact. Awarding her this recognition would not only honor her achievements but also inspire further excellence in translational medical research.